Synarc Unveils New Branding Campaign   

Creative concept reflects company's broad impact on health care

San Francisco – May 16, 2007 - Synarc Inc., the world's leading provider of medical image analysis, biochemical marker, and subject recruitment services to the pharmaceutical and biotechnology industries, today announced its new branding campaign entitled "The Planet."

The campaign will include the roll-out of a new logo, tag-line and overall creative approach that reflects Synarc's stature as a global leader in enhancing the efficiency of clinical trials.   Synarc's medical image analysis, biochemical marker, and subject recruitment services are currently used in more than 200 clinical trials around the world.

"Synarc's "The Planet" campaign represents aspiration and challenge," said president and chief executive officer Gary Velasquez. "It also reflects how being a global company will assist our customers achieve their objectives of getting products into the marketplace faster."

The new tag-line "Start here, finish first" embodies Synarc's commitment and expertise in precise medical image analysis, biochemical marker, and subject recruitment and retention services. Synarc employs over 600 scientists, expert researchers, technicians and business support staff.

The campaign will encompass all of Synarc's collateral material from internal documents to trade show displays and marketing material. Plans for the future include a reengineered company web site, www.synarc.com

Synarc was formed in 1998 and since then has contributed to the approval of more leading compounds, across a broad spectrum of therapeutic areas, than any other central imaging provider.

About Synarc
Synarc’s medical image analysis, subject recruitment and biochemical marker services enable life-science industry clients to execute clinical trials accurately while decreasing the time, uncertainty, and cost of product development. Synarc has partnered with industry leaders to bring numerous leading compounds to market across a broad spectrum of therapeutic areas. Our services integrate critical aspects of clinical-trial design and execution, from protocol design and subject recruitment to regulatory liaison on behalf of our clients.  Our expert radiologists and scientists are innovators in all aspects of medical image analysis and biochemical markers in drug development, and have pioneered many methods used in today’s clinical trials. Synarc has seventeen offices around the world. Synarc's medical image analysis, subject recruitment and biochemical marker services are currently used in more than 200 clinical trials around the world.

Media Contact:
Victoria Swanson
415 817-7912
victoria.swanson@synarc.com